I hear you Cro, no-one wants unsafe medicine, but also many people die from lack of treatment while good medicines are held up there needs to be a good balance between to two.
"GlaxoSmithKline and AstraZeneca and Pfizer and Novartis and Hoffman-La Roche and Genentech and Eli Lilly " that is a good list you should send them TIS reports to their CFO's a takeover by a drug company with deep pockets might be a good outcome.
No I definitely dont work at TIS or QUT or any associated companies just a financial controller / private company owner in an unrelated industry. Dont normally do small caps but had some good fortune with Sirtex and researched a number of small cap biotechs of the eight I looked I thought TIS was best bet as most of the pain seemed to be over, but no CE yet.
TIS Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held